This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Postoperative Stress Accelerates Atherosclerosis Through Inflammatory Remodeling of the HDL Proteome and Impaired Reverse Cholesterol Transport.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
Sox9-dependent acquisition of a drug resistant "memory state" induces reciprocal expression of Sox6 and Sox7 in BRAF melanoma.
Biochimica et biophysica acta. Molecular cell research · 2026
LAG3 Marks Activated but Hyporesponsive NK Cells.
European journal of immunology · 2025
Latest funding
- $10,000
SWEETN-CVD: Artificial SWEEteners as New risk factor for CardioVascular Disease
CIHR · 2026 · Co-investigator
- $1,025,100
Targeting cancer cell plasticity to improve outcomes in high-grade serous ovarian cancer
CIHR · 2025 · Nominated PI
- $140,000
HLA-mediated epitype-immune interactions in high-grade serous ovarian cancer
CIHR · 2025 · Supervisor
5 publications.
Postoperative Stress Accelerates Atherosclerosis Through Inflammatory Remodeling of the HDL Proteome and Impaired Reverse Cholesterol Transport.
Boucher DM, Lorant V, Rochon V, Carter A, Stotts C, Nguyen MA, Laval T, Emerton C, Joyce N, Vinayak N, Scaffidi M, Cook D, Rayner KJ, Auer RC, Gordon SM, Ouimet MI
Sox9-dependent acquisition of a drug resistant "memory state" induces reciprocal expression of Sox6 and Sox7 in BRAF melanoma.
Abou-Hamad J, Delisle S, Garland B, Hersi M, Cook D, Sabourin LA
LAG3 Marks Activated but Hyporesponsive NK Cells.
Vasilyeva V, Makinson O, Chan C, Park M, O'Dwyer C, Ali A, Khan AUH, de Souza CT, Hasim MS, Asif S, Kurdieh R, Abou-Hamad J, Yakubovich E, Hodgins J, Haddad PA, Pietropaolo G, Mazej J, Seo H, Huang Q, Nersesian S, Chay D, Jacquelot N, Cook D, Lee SH, Sciumè G, Waggoner S, Ardolino M, Marotel M
Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.
Zhu Y, Abedini A, Rodriguez GM, McCloskey CW, Abou-Hamad J, Salah OS, Larocque J, Tsoi MF, Boerboom D, Cook D, Vanderhyden B
Society for Simulation in Healthcare Guidelines for Simulation Training.
Stefanidis D, Cook D, Kalantar-Motamedi SM, Muret-Wagstaff S, Calhoun AW, Lauridsen KG, Paige JT, Lockey A, Donoghue A, Hall AK, Patocka C, Palaganas J, Gross IT, Kessler D, Vermylen J, Lin Y, Aebersold M, Chang TP, Duff J, Kolbe M, Rutherford-Hemming T, Decker S, Collings A, Toseef Ansari M
SWEETN-CVD: Artificial SWEEteners as New risk factor for CardioVascular Disease
Principal investigators: Rayner, Katey; De Lisio, Michael
Keywords: Artificial Sweeteners; Atherosclerosis; Cardiovascular; Epigenetics; Inflammation
Targeting cancer cell plasticity to improve outcomes in high-grade serous ovarian cancer
Principal investigators: Cook, David P
Keywords: Cancer Therapeutics; Cell Plasticity; Genomics; Ovarian Cancer; Targeted Therapy; Tumour Microenvironment
HLA-mediated epitype-immune interactions in high-grade serous ovarian cancer
Principal investigators: Nersesian, Sarah
Keywords: Cancer Immunotherapy; Hla Regulation; Immune Evasion; Immune Microenvironment; Multiple Immunofluorescence; Ovarian Cancer; Single-Cell Transcriptomics; Spatial Transcriptomics; Tumour Heterogeneity; Tumour-Immune Interactions
Ethnic and racial disparity in endometriosis pathobiology, diagnosis, and treatment
Principal investigators: Singh, Sukhbir S; Tsang, Benjamin K
Keywords: Diagnostics; Endometriosis; Endometriotic Lesions; Ethnicity; Immunology; Machine Learning; Personalized Medicine; Proteomics; Race; Whole Genome Sequencing
Cellular plasticity and adaptation to cyclic chemotherapy treatment in ovarian cancer
Principal investigators: Durocher, Emma M
Keywords: Bioinformatics; Cell Signalling; Cellular Plasticity; Chemotherapy Resistance/Tolerance; Drug Adaptation; Organoids; Ovarian Cancer
Harnessing ILC2 for immunotherapy of ovarian cancer.
Principal investigators: Ardolino, Michele
Keywords: Immunotherapy; Innate Immunity; Innate Lymphoid Cells; Oncolytic Viruses; Ovarian Cancer; Tumor Immunology
Increasing anti-tumoral responses to ovarian cancer using engineered viruses
Principal investigators: Vanderhyden, Barbara C
Keywords: Cytokines; Cytotoxic T Lymphocytes; Immune Surveillance; Immune System Response; Immunopeptidome; Immunotherapy; Mhc I; Nlrc5; Oncolytic Virus; Ovarian Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Biochemistry, Microbiology and Immunology
- Cellular and Molecular Medicine
- Biochemistry and Molecular Biology
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Catherine Patocka
Faculty
1 shared papers, latest 2024
Seung-Hwan Lee
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2025
Barbara Vanderhyden
Cellular and Molecular Medicine
1 shared papers, latest 2025
Michele Ardolino
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2025
Nicolas Jacquelot
Biochemistry and Molecular Biology
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.